s-nitrosoglutathione has been researched along with deferoxamine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hogg, N; Kalyanaraman, B; Struck, AT; Thomas, JP | 1 |
Choi, BM; Chung, HT; Kang, CL; Kim, JD; Pae, HO; Yoo, JC | 1 |
Chiueh, CC; Rauhala, P; Spooner, CM; Van Bergen, P | 1 |
Brüne, B; Fandrey, J; Sandau, KB | 1 |
Richardson, DR; Watts, RN | 1 |
Brüne, B; Callapina, M; Deitmer, JW; Lohr, C; Metzen, E; Schnitzer, S; Zhou, J | 1 |
Bartosz, G; Lewinska, A | 1 |
7 other study(ies) available for s-nitrosoglutathione and deferoxamine
Article | Year |
---|---|
Nitric oxide donor compounds inhibit the toxicity of oxidized low-density lipoprotein to endothelial cells.
Topics: Animals; Aorta, Thoracic; Butylated Hydroxytoluene; Cattle; Cell Survival; Deferoxamine; Dose-Response Relationship, Drug; Endothelium, Vascular; Glutathione; Glutathione Disulfide; Kinetics; Lipid Peroxides; Lipoproteins, LDL; Nitric Oxide; Nitroso Compounds; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Selenium; Spermine | 1995 |
Apoptotic cell death induced by taxol is inhibited by nitric oxide in human leukemia HL-60 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Deferoxamine; DNA Fragmentation; G1 Phase; Glutathione; Growth Inhibitors; HL-60 Cells; Humans; Mimosine; Nitric Oxide; Nitroso Compounds; Paclitaxel; S Phase; S-Nitrosoglutathione | 1999 |
Hemoglobin and iron-evoked oxidative stress in the brain: protection by bile pigments, manganese and S-nitrosoglutathione.
Topics: Animals; Antioxidants; Bile Pigments; Bilirubin; Biliverdine; Brain; Citric Acid; Deferoxamine; Ferrous Compounds; Glutathione; Hemoglobins; Iron; Lipid Peroxidation; Male; Manganese; Muscle, Skeletal; Nitroso Compounds; Oxidants; Oxidative Stress; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione; Tissue Extracts | 1999 |
Accumulation of HIF-1alpha under the influence of nitric oxide.
Topics: Animals; Benzoates; Cell Hypoxia; Cell Line; Cobalt; Coculture Techniques; Deferoxamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Glutathione; Guanylate Cyclase; Hydrazines; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Inflammation; Kidney Tubules, Proximal; Macrophage Activation; Macrophages; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Nitroso Compounds; Nuclear Proteins; Oxadiazoles; Oxazines; S-Nitrosoglutathione; Spermine; Swine; Transcription Factors | 2001 |
The mechanism of nitrogen monoxide (NO)-mediated iron mobilization from cells. NO intercepts iron before incorporation into ferritin and indirectly mobilizes iron from ferritin in a glutathione-dependent manner.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Membrane Permeability; Cell-Free System; Cytosol; Deferoxamine; Female; Ferritins; Fibroblasts; Glutathione; Humans; Iron; Iron Chelating Agents; Macrophage Activation; Mice; Neuroblastoma; Neuroectodermal Tumors, Primitive, Peripheral; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Oxidation-Reduction; Penicillamine; S-Nitrosoglutathione; Spermine; Tumor Cells, Cultured | 2002 |
Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
Topics: Amino Acids, Dicarboxylic; Caspase 3; Caspases; Cell Hypoxia; Cell Line; Cysteine Proteinase Inhibitors; Deferoxamine; Enzyme Inhibitors; Ferric Compounds; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Iron; Leupeptins; Nitric Oxide; Nitric Oxide Donors; Procollagen-Proline Dioxygenase; Proteasome Endopeptidase Complex; Proteasome Inhibitors; S-Nitrosoglutathione; Transcription Factors; Triazenes; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein | 2005 |
Yeast flavohemoglobin protects against nitrosative stress and controls ferric reductase activity.
Topics: Cell Division; Deferoxamine; Dioxygenases; Dose-Response Relationship, Drug; Ferricyanides; FMN Reductase; Gene Deletion; Hemeproteins; Hydrogen Peroxide; Mutation; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxidation-Reduction; Penicillamine; Peroxynitrous Acid; S-Nitrosoglutathione; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sodium Hypochlorite; Time Factors | 2006 |